《美國股市》道指升幅擴至逾200點 微軟領漲3%
美股於今早輕微高開後,升幅擴大,截至香港時間晚上11時54分,道指最新升281.11點或0.83%,報34,150.38點;標普50指數升34.59點或0.86%,報4,125.57點;納指報11,853.95點,升133.63點或1.16%。
科技股為表現最好板塊,漲幅超過1%,微軟(MSFT.US)升3.3%,夥同Salesforce(CRM.US)升1.6%,齊齊領升道指。
美國將於周二公布1月份消費者價格指數,將反映央行加息情況下,通脹能否持續放緩。
本周亦有不少業績,包括可口可樂(COKE.US)、萬豪(Marriott)(MAR.US)及思科(CISCO)(CSCO.US)
等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.